Antibodies specific for seroreactive regions on HPV 16 protein E1
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 20, 2004
Grant Date -
Aug 7, 2003
app pub date -
Jan 13, 2003
filing date -
Jul 18, 1991
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention relates to seroreactive regions on proteins E1 and E2 of human papillomavirus (HPV) 16. The application also relates to a vaccine which contains such peptides which contain the seroreactive regions. The invention likewise embraces compositions for diagnostic purposes which contain peptides with the seroreactive regions.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully